78 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
scheduled milestone payments. Should it be deemed not to be YOFOTO's fault in not meeting its milestone targets, the Company may have the risk of having
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
to a YOFOTO-owned Canadian subsidiary, with detailed assignment reversion rights upon failure to meet defined targets. At the date of these financial
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
RepliCel not to receive its scheduled milestone payments. Should it be deemed not to be YOFOTO's fault in not meeting its milestone targets, the Company may
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
targets. At the date of these financial statements, no such Chinese patents have been assigned to YOFOTO.
On October 9, 2018, the $5,090,005 private
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
to meet defined targets. At the date of these financial statements, no such Chinese patents have been assigned to YOFOTO. On October 9, 2018
6-K
EX-99.2
ztkz3d 2u4x
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
g3ovq7bh
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
v3n8jy4
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
k1622s4
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
b5j85wxr
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
doo7yky34wjr6df
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
29of9vv5uo9 fdccaw
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
kzukl8y26dqrpm
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
k943jyiueya8w3di
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
71p7p5fmdpnyb21bxs
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
2wuwf0p 29wmzl
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
agb7l2 k9o4
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
sfs4d3tdot56qrp
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am